'Here, we chose to study how centrosome amplification influences the response to combined Carboplatin and Paclitaxel in the context of epithelial ovarian cancer, a disease with poor clinical outcome related to late diagnosis, and frequent relapse'

https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3002759